Skip to main content
The Journal of Neuroscience logoLink to The Journal of Neuroscience
. 1993 Jul 1;13(7):3104–3111. doi: 10.1523/JNEUROSCI.13-07-03104.1993

GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+

A Dalia 1, NH Neff 1, M Hadjiconstantinou 1
PMCID: PMC6576684  PMID: 8101212

Abstract

Rat embryonic mesencephalic cultures were employed to evaluate the consequences of adding GM1 ganglioside to cultures lesioned with the selective neurotoxin 1-methyl-4-phenylpyridinium (MPP+). MPP+ reduced dopamine and DOPAC content, dopamine uptake, aromatic L-amino acid decarboxylase activity, and the number of tyrosine hydroxylase- immunopositive neurons. The immunopositive neurons that remained were aberrant. All of these parameters were partially restored by adding GM1 ganglioside to the cultures. The response to GM1 was not altered by prior treatment of the cultures with cytosine beta-D-arabinofuranoside to reduce the number of glial cells. Dopamine uptake activity restored by GM1 was lost if GM1 was removed from the culture.


Articles from The Journal of Neuroscience are provided here courtesy of Society for Neuroscience

RESOURCES